Jared Holz, Mizuho, joins ‘Fast Money’ to talk the uptick in biotech and pharma M&A, what it is signaling, and how to play it.
05:29
Fri, Nov 14 20255:58 PM EST
Trending
- Hot tech stock ETFs are sitting on big gains. Is it time to sell?
- Jefferies upgrades this retailer on emerging opportunity in beauty business
- Berkshire Hathaway takes new stake in Alphabet, decreases Apple stake in Q3
- AI to impact 89% of jobs next year, CNBC survey of HR leaders finds
- AI companies admit they’re worried about a bubble
- We’re looking to further trim this drug stock and exit this entertainment giant
- The tiny Greek island where EVs take charge
- Stocks making the biggest moves midday: WHR, MODG, NVDA, STUB
If M&A continues at this pace you want to be long Biotech into next year, says Mizuho’s Jared Holz
